Sky Century Investment (SKYI) Non-Current Assets (2024 - 2026)
Sky Century Investment (SKYI) posted quarterly Non-Current Assets of $115499.0 for Q2 2026, up 5.6% year-over-year from $109375.0 in Q2 2025, and up 11.35% quarter-over-quarter from $103726.0 in Q1 2026.
Sky Century Investment (SKYI) Non-Current Assets (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Non-Current Assets for 3 consecutive years, with $115499.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets rose 5.6% year-over-year to $115499.0; the TTM figure through May 2026 stood at $438296.0 (up 81.52% YoY), while the FY2025 annual figure was $109765.0, up 57.97% from the prior year.
- Non-Current Assets improved to $115499.0 in Q2 2026 per SKYI's latest filing, from $103726.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $115499.0 in Q2 2026 and bottomed at $62598.0 in Q1 2025.
- Historically, Non-Current Assets has averaged $97107.6 across 3 years, with a median of $109306.0 in 2025.
- On a YoY basis, Non-Current Assets climbed as much as 65.7% in 2026 and fell as far as 5.6% in 2026.
- Sky Century Investment's Non-Current Assets stood at $69484.0 in 2024, then soared by 57.31% to $109306.0 in 2025, then grew by 5.67% to $115499.0 in 2026.
- Business Quant data shows SKYI's Non-Current Assets at $115499.0 in Q2 2026, $103726.0 in Q1 2026, and $109306.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 115,499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 115,499.00 |
| Feb 28, 2026 | 103,726.00 |
| Nov 30, 2025 | 109,306.00 |
| Aug 31, 2025 | 109,765.00 |
| May 31, 2025 | 109,375.00 |
| Feb 28, 2025 | 62,598.00 |
| Aug 31, 2024 | 69,484.00 |